Pre-clinical studies reported a higher low-density lipoprotein receptor (LDLR) expression in some malignant tumors such as colon cancer where low-density lipoprotein (LDL) increased the proliferation of these tumor cells through the MAPK signaling pathway [16]. The gene discussed is LDLR; the disease is malignant colon neoplasm.